The FDA has accepted Pharming Group’s supplemental new drug application for leniolisib in treating activated phosphoinositide ...

Women are increasingly being diagnosed as neurodivergent later in life, giving them a better understanding of their personal ...

New research reveals how complex interactions between genetic variants can explain different outcomes in disorders like ...

Cerebral cavernous malformations are clustered capillaries with abnormally thin walls, resulting in leaky, delicate blood ...

Beauty standards are boring. What falls outside the norm is much more interesting, and some features cannot be bought or ...

Climate change is rapidly altering our environment—and posing major challenges for many animal species. Whether they can ...

Alternative splicing exhibits lineage-specific variability, with mammals and birds reaching the highest levels despite conserved intron-rich architectures, while unicellular eukaryotes and prokaryotes ...

In the U.S., the generic name for Libtayo in its approved indications is cemiplimab-rwlc, with rwlc as the suffix designated in accordance with Nonproprietary Naming of Biological Products Guidance ...

Multi-omics study utilizing electronic genome mapping (EGM) reveals 70% of patients with interstitial cystitis/bladder pain syndrome (IC/BPS) have ...

Emerging evidence indicates that sustainable lifestyle changes—such as increasing physical activity, adopting healthy dietary ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced new and updated data from its advancing oncology pipeline will be shared in seven abstracts at the European Society for Medical Oncology ...